Cerebrospinal fluid levels of antiretroviral medications: abstract and commentary.
Tashima
K T
KT
Assistant Professor of Medicine, Brown University, Providence, RI, USA. Karen_Tashima@brown.edu
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D001812:Blood-Brain Barrier; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000134:cerebrospinal fluid* / Q000188:drug therapy*; D015497:HIV-1 / Q000302:isolation & purification*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use; D012367:RNA, Viral / Q000134:cerebrospinal fluid; D018119:Stavudine / Q000627:therapeutic use; D015215:Zidovudine / Q000627:therapeutic use
D019380:Anti-HIV Agents; D012367:RNA, Viral; D019259:Lamivudine; D015215:Zidovudine; D018119:Stavudine